![](/img/cover-not-exists.png)
3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs)
Horn, L., Brahmer, J., Reck, M., Borghaei, H., Spigel, D.R., Steins, M., Ready, N.E., Chow, L.Q., Vokes, E.E., Felip, E., Holgado, E., Barlesi, F., Kohlhäufl, M.J., Burgio, M.A., Fayette, J., GettingeVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)31655-0
Date:
September, 2015
File:
PDF, 60 KB
english, 2015